|
2025
|
Invention
|
Crystalline forms or amorphous forms of n-(phenyl sulfonyl) benzamide compounds or its salts or s... |
|
|
Invention
|
Pharmaceutical combination containing bcl-2/bcl-xl inhibitor and use thereof. The present inventi... |
|
|
Invention
|
N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors.
Described herein are met... |
|
|
Invention
|
Treatment method with focal adhesion kinase inhibitor. A method for treating cancer, especially s... |
|
|
Invention
|
Use of mdm2 inhibitor and method of use. Provided is use of an MDM2 inhibitor in weight managemen... |
|
|
Invention
|
Methods of treating tki-resistant and sdh-deficient gist. Provided herein is a method of treating... |
|
|
Invention
|
Pharmaceutical combination and use thereof.
The invention discloses a novel pharmaceutical combi... |
|
|
Invention
|
Therapy for fgfr1 rearrangement-related cancer. The compound I and its use for treating or preven... |
|
|
Invention
|
Method for preparing alk inhibitor compound and intermediate thereof. Disclosed in the present in... |
|
2024
|
Invention
|
A pharmaceutical combination and the use thereof. Provided herein is the pharmaceutical combinati... |
|
|
Invention
|
Novel compounds as iap antagonists. The present disclosure relates to compounds that inhibit IAP ... |
|
|
Invention
|
Pharmaceutical composition containing alkynyl compound and preparation method and application the... |
|
|
Invention
|
Eed inhibitor solid dispersion, oral formulation comprising same, and preparation method therefor... |
|
|
Invention
|
Bcl-2/bcl-xl protein degrader and use thereof. Provided are compounds that function as degraders ... |
|
|
Invention
|
Pharmaceutical composition and use thereof. A pharmaceutical composition and the use thereof. Spe... |
|
|
Invention
|
Kras inhibitors. The present disclosure relates to compounds that inhibit KRAS. In particular, th... |
|
|
Invention
|
Crystal form of alk inhibitor or salt and solvate thereof, preparation method therefor, and use t... |
|
2023
|
Invention
|
Combination therapies for treating cancer.
The present invention relates to one or more combinat... |
|
|
Invention
|
Tricyclic heterocycle compounds as iap antagonists.
The present disclosure relates to compounds ... |
|
|
Invention
|
Tricyclic heterocycle compounds as iap antagonists. The present disclosure relates to compounds t... |
|
|
Invention
|
Methods for treating immune diseases.
Methods for treating immune diseases, specifically methods... |
|
|
Invention
|
Methods for treating immune diseases. Methods for treating immune diseases, specifically methods ... |
|
|
Invention
|
Crystalline form or amorphous form of macrocyclic compound or salt or solvate thereof.
Disclosed... |
|
|
Invention
|
Crystalline form or amorphous form of macrocyclic compound or salt or solvate thereof. Disclosed ... |
|
|
Invention
|
Methods for treating aml-mrc and mds.
Provided are methods for treating hematologic malignancy, ... |
|
|
Invention
|
Methods for treating aml-mrc and mds. Provided are methods for treating hematologic malignancy, e... |
|
2022
|
Invention
|
Kras inhibitors.
The present disclosure relates to compounds that inhibit KRAS. In particular, t... |
|
|
Invention
|
Kras inhibitors. Disclosed relates to compounds that inhibit KRAS. In particular, disclosed relat... |
|
|
Invention
|
Methods of treating a disease or disorder.
Disclosed is a method for preventing and/or treating ... |
|
|
Invention
|
Methods of treating a disease or disorder. Disclosed is a method for preventing and/or treating a... |
|
|
Invention
|
A pharmaceutical combination and use thereof.
The present invention pertains to the pharmaceutic... |
|
|
Invention
|
Pharmaceutical combination and use thereof. The present invention relates to the field of medicin... |
|
|
Invention
|
A pharmaceutical combination and use thereof.
Provided herein are the pharmaceutical combination... |
|
|
Invention
|
Sulfonyl benzamide derivatives as bcl-2 inhibitors.
The present disclosure provides compounds ha... |
|
2021
|
Invention
|
Methods of treating multiple sclerosis.
Disclosed are methods of treating multiple sclerosis. Th... |
|
|
Invention
|
A composition comprising heterocyclic compounds, preparation method and application thereof.
Pro... |
|
|
Invention
|
A pharmaceutical composition and use thereof for treatment of cancer.
Provided herein in the bio... |
|
|
Invention
|
Compositions and methods for treating non-alcoholic steatohepatitis.
Methods for treating non-al... |
|
|
Invention
|
Compositions and methods for treating systemic lupus erythematosus.
Methods for treating systemi... |
|
|
Invention
|
The crystalline forms or amorphous forms of bisdiazabicyclic compounds or salts thereof.
Crystal... |
|
|
Invention
|
Crystalline or amorphous form of bcl-2/bcl-xl inhibitor compound or its salts.
Disclosed herein ... |
|
|
Invention
|
Methods for synthesizing n-(phenylsulfonyl)benzamide compounds and intermediates thereof.
Disclo... |
|
|
Invention
|
Crystals of alkynyl-containing compound, salt and solvate thereof, preparation method, and applic... |
|
|
Invention
|
Microsuspension of an mdm2 inhibitor and therapeautic applications thereof.
Provided herein is a... |
|
|
Invention
|
Methods for treating coronavirus infections.
A method for treating patients with viral infection... |
|
|
Invention
|
Novel medical use of mdm2 inhibitors.
Provided use of MDM2 inhibitors alone or in combination wi... |
|
|
Invention
|
Amorphous form or crystalline form of 2-indolinolinololylspironone compounds or their salts, sol... |
